NCT02904265View on ClinicalTrials.gov

Efficacy Study of Acetazolamide Versus Diazepam in Continuous Spike and Wave/Landau-Kleffner Syndrome

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

July 26, 2019

Study Completion Date

July 26, 2019

Conditions
Landau-Kleffner SyndromeStatus Epilepticus, Electrographic
Interventions
DRUG

Diazepam

DRUG

Acetazolamide

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER